Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-013509
Filing Date
2017-08-02
Accepted
2017-08-01 18:36:38
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20170630_10q.htm 10-Q 1409409
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 39585
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 10024
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7669
  Complete submission text file 0001437749-17-013509.txt   5355517

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS acrx-20170630.xml EX-101.INS 1097851
6 EXHIBIT 101.SCH acrx-20170630.xsd EX-101.SCH 53986
7 EXHIBIT 101.CAL acrx-20170630_cal.xml EX-101.CAL 35464
8 EXHIBIT 101.DEF acrx-20170630_def.xml EX-101.DEF 306448
9 EXHIBIT 101.LAB acrx-20170630_lab.xml EX-101.LAB 268240
10 EXHIBIT 101.PRE acrx-20170630_pre.xml EX-101.PRE 321686
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 17997905
SIC: 2834 Pharmaceutical Preparations